This conversation is closed.
What is the true research & development costs for my HIV medication Atripla manufactured by Gilead?
I've heard PhRMA CEOs qoute that it cost $1.2 Billion dollars to bring a new medicine to market. While I acknowledge pharmaceuticals is a high risk enterprise, I'm skeptical of this figure and thought, as a patient dependent on an expensive medication to survive, asking the TED universe would be useful.
I take Atripla, the most common one pill once a day treatment prescribed in US, for my HIV. My Atripla cost $60 a pill. I know manufacturers in India produce a generic version, Vidicay, for substantially less. I also know Atripla, in some respects, is an example of evergreening given the single pill is actually 3 separate medications in one.
The main reason I'm asking this is I am working diligently to protect public health from being compromised by the IP provisions of the Trans Pacific Partnership and the TTIP.
In my work I often speak with people about the global successes of scaling up HIV treatments through generic medicines. I speak with people about my life as well and in so doing, it would be useful for me to know the true R & D cost that went into my medication. An answer I have found to be very tough to come by.